Tellimer

KR : Inbody Co Ltd - Back on the growth highway

Inbody reported total sales/OP of W33bn/W10.2bn (+18.7%/+83.4% yoy) mainly driven by reopening of fitness centres in Korea in 1Q21. We forecast Inbody to report OP of W30bn/W35bn (+55%/+19% yoy) in FY21/22F thanks to firm topline growth in professional/consumer-use BCAs. Reiterate Add with a new TP of W36,000 based on FY21-22F EPS average and 17x FY22F P/E. This note marks the transfer of coverage to Jiwon Lee.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers